Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.
- DOI
- 10.1038/sj.leu.2402847
- Published
- 2003 Mar
- Container
- Leukemia
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/sj.leu.2402847,
title = {Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.},
author = {Navolanic PM and Pui CH and Larson RA and Bishop MR and Pearce TE and Cairo MS and Goldman SC and Jeha SC and Shanholtz CB and Leonard JP and McCubrey JA},
year = {2003},
journal = {Leukemia},
doi = {10.1038/sj.leu.2402847},
url = {https://doi.org/10.1038/sj.leu.2402847}
}RIS
TY - JOUR TI - Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002. AU - Navolanic PM AU - Pui CH AU - Larson RA AU - Bishop MR AU - Pearce TE AU - Cairo MS AU - Goldman SC AU - Jeha SC AU - Shanholtz CB AU - Leonard JP AU - McCubrey JA PY - 2003 JO - Leukemia DO - 10.1038/sj.leu.2402847 UR - https://doi.org/10.1038/sj.leu.2402847 ER -
APA
PM, N., CH, P., RA, L., MR, B., TE, P., MS, C., SC, G., SC, J., CB, S., JP, L., & JA, M. (2003). Elitek-rasburicase: an effective means to prevent and treat hyperuricemia associated with tumor lysis syndrome, a Meeting Report, Dallas, Texas, January 2002.. Leukemia. https://doi.org/10.1038/sj.leu.2402847
Source records
- pubmed · retrieved 2026-09-25T11:11:13.231Z